Herlev University Hospital
Herlev, 2730, Denmark
NCT Number: NCT04997525
The aim of the present study is to investigate serum estradiol and progesterone levels in women conceiving after natural, estradiol + progesterone or gonadotropin stimulated frozen embryo transfer (FET) cycles.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Phase 4
Herlev, 2730, Denmark
Enrolled women will be randomized based on their ovulation pattern. Ovulatory women will be randomized to either natural cycle or estradiol + progesterone substituted cycle treatment for FET. Anovulatory women will be randomized to either estradiol + progesterone substituted cycle or gonadotropin stimulated cycle treatment for FET.
Included women will undergo blood testing every two weeks for serum estradiol and progesterone levels until gestational age 9+6. Routine vaginal ultrasounds will be performed as well as additional pregnancy ultrasounds.
Secondary obstetric outcomes will be investigated using the womens medical journals.
All the treatments are considered standard treatments for FET.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Combined with progesterone
Combined with estradiol
Combined with hCG
In either natural cycle or combined with Follitropin Alfa
Time frame: 10 weeks
Blood samples in the first 10 weeks of pregnancy
Time frame: 10 weeks
Blood samples in the first 10 weeks of pregnancy
Time frame: At delivery
Weeks of pregnancy when the child has been delivered
Time frame: At delivery
Weight of the child at delivery
Time frame: 9 months
Obsteric complication throughout pregnancy
Time frame: 9 months
Child malformations diagnosed in utero or at delivery
Copenhagen University Hospital at Herlev
Other
Estradiol and Progesterone Levels in Early Pregnancy After Natural, Estradiol + Progesterone or Gonadotrophin Stimulated Frozen Embryo Transfer Cycle
Acronym: ESTRO-FET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details